Oseltamivir phos 75 MG capsule UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HK2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,570
Award facts
- Contract value 100% obligated
- $14,569.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10, with a contract ceiling value of $14,569.51 and an ultimate completion date of December 29, 2025. This firm fixed price delivery order, which is not associated with a set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used to treat and prevent influenza infections across military and defense healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that enables the contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, consistently fulfills federal medical procurement requirements through competitive awards and serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio includes specialty medications, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a key provider within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9HK2?
SPE2DR26F9HK2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26F9HK2 worth?
The government has obligated $14,570 on SPE2DR26F9HK2.
Is contract SPE2DR26F9HK2 an order under another contract?
Yes. SPE2DR26F9HK2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HK2 competed?
The extent of competition for SPE2DR26F9HK2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award